Join experts from Cleveland Clinic and around the world at a CME-certified official review in Hollywood, Florida.
Cleveland Clinic oncologists conducted a new meta-analysis of breast cancer lumpectomy patients to determine the best margins to prevent additional surgery and optimize long-term survival.
Five-year follow-up data from the Prevention of Early Menopause Study shows use of goserelin, a gonadotropin hormone-releasing hor-mone agonist, along with standard chemotherapy, helps preserve fertility in women with breast cancer.
A retrospective review found that the presence of variants of uncertain significance on multigene panel testing does not increase the rate of contralateral prophylactic mastectomies.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
New guidelines for APBI expand its availability to younger patients.
A study comparing healthy and malignant breast tissue found more Methylobacterium in malignant breast tissue.
Depression, anxiety are common in women at genetic risk for breast cancer. Counseling can give them the impetus to embrace preventive measures.
Cleveland Clinic surgeons have developed a technique that expands the indications for nipple-sparing mastectomy beyond small tumors outside of the nipple areolar complex.
Primary care physicians play a vital role in detecting cancers at earlier stages. Accurate diagnosis of breast cancer is vital, and early diagnosis can reduce mortality.
Researchers found that Ki67 levels are a good predictor of which breast cancer patients might do well on endocrine therapy alone, but not of those who might do well on chemotherapy if the endocrine therapy failed.